Pozo Carmen, Pradere Benjamin, Rebhan Katharina, Chao Cao, Yang Lin, Abufaraj Mohammad, Shariat Shahrokh F
Department of Urology, Medical University of Vienna, Vienna, Austria.
Department of Urology, CHRU Tours, Francois Rabelais University, Tours, France.
Bladder Cancer. 2021 Aug 31;7(3):365-376. doi: 10.3233/BLC-201526. eCollection 2021.
Patients undergoing intestinal urinary diversion (IUD) may have a higher risk of osteoporosis and risk of fractures due to metabolic acidosis and decrease of intestinal absorption surface.
We performed a systematic review of the available literature on the impact of IUD on bone demineralization.
We systematically searched PubMed, for original articles published before April 2020. Primary end points were the risk of fracture and loss of bone density. Secondary outcomes were the metabolic changes in biochemical and urine parameters related to calcium metabolism and histological changes.
Our electronic search identified a total of 2417 articles. After a detailed review, we selected 11 studies that addressed the impact of IUD on bone health in 10369 patients. The risk of bone fracture was studied in 3 articles, showing a higher risk in the IUD population. Of the 9 articles evaluating the relation between intestinal urinary diversion and bone density, 5 did find a positive association. One article evaluated the bone metabolism at a cellular level after IUD showing a decrease in bone turnover in this population. Three of the eight studies reporting data on serum parameters related to calcium and phosphate metabolism showed differences. Finally, a correlation between concentration of pyridolines in urine and loss of bone density was found in two of the three studies.
Although published data on BMD are contradictory, patients undergoing IUD seem to be at higher risk of bone fractures. Our finding support the need to implement accessible strategies on osteoporosis screening and prevention in IUD patients.
接受肠道代膀胱术(IUD)的患者可能因代谢性酸中毒和肠道吸收面积减少而有更高的骨质疏松风险和骨折风险。
我们对现有关于IUD对骨脱矿影响的文献进行了系统综述。
我们系统检索了PubMed,查找2020年4月之前发表的原始文章。主要终点是骨折风险和骨密度丧失。次要结局是与钙代谢相关的生化和尿液参数的代谢变化以及组织学变化。
我们的电子检索共识别出2417篇文章。经过详细审查,我们选择了11项研究,这些研究涉及IUD对10369例患者骨骼健康的影响。3篇文章研究了骨折风险,显示IUD人群的风险更高。在9篇评估肠道代膀胱术与骨密度关系的文章中,有5篇确实发现了正相关。1篇文章评估了IUD后细胞水平的骨代谢,显示该人群骨转换减少。八项报告钙和磷代谢相关血清参数数据的研究中有三项显示出差异。最后,在三项研究中的两项中发现尿中吡啶啉浓度与骨密度丧失之间存在相关性。
尽管关于骨密度的已发表数据相互矛盾,但接受IUD的患者似乎骨折风险更高。我们的研究结果支持有必要对IUD患者实施可及的骨质疏松筛查和预防策略。